Amgen Inc. BDR | |
Stock Exchange | Brazilian Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
- |
Public Float |
- |
Amgen Inc. | |
Stock Exchange | Xetra Stock Exchange |
EPS |
EUR10.83 |
Market Cap |
EUR102.14 B |
Shares Outstanding |
661.71 M |
Public Float |
667.54 M |
Amgen Inc. | |
Stock Exchange | Mexican Stock Exchange |
EPS |
MXN242.71 |
Market Cap |
MXN2.15 T |
Shares Outstanding |
661.71 M |
Public Float |
667.54 M |
Amgen Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$12.54 |
Market Cap |
$113.41 B |
Shares Outstanding |
609.94 M |
Public Float |
621.01 M |
Address |
One Amgen Center Drive Thousand Oaks California 91320 United States |
Employees | - |
Website | http://www.amgen.com |
Updated | 07/08/2019 |
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. |